🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

IQVIA Holdings Inc (IQV)

NYSE
Currency in USD
219.23
+1.55(+0.71%)
Closed
After Hours
219.230.00(0.00%)
IQV Scorecard
Full Analysis
14 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
216.74222.04
52 wk Range
191.45261.73
Prev. Close
217.68
Open
217.47
Day's Range
216.74-222.04
52 wk Range
191.45-261.73
Volume
1,418,430
Average Volume (3m)
1,124,589
1-Year Change
11.86%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
IQV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
255.70
Upside
+16.64%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

IQVIA Holdings Inc Company Profile

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

InvestingPro Research for IQVIA Holdings Inc


Market Dominance
Explore IQVIA's position as the world's largest Contract Research Organization, offering comprehensive services for drug development and commercialization
Financial Trajectory
Analysts project EPS of 11.23 for FY1 and 12.38 for FY2, with expectations of reacceleration as multi-year headwinds fade
Competitive Edge
Delve into IQVIA's proprietary data and technology assets, providing unique insights and efficiency in clinical trials and drug development
Future Prospects
Learn about IQVIA's potential for valuation re-rating and growth opportunities in Data/AI within the healthcare secto
Read full SWOT analysis

Compare IQV to Peers and Sector

Metrics to compare
IQV
Peers
Sector
Relationship
P/E Ratio
28.3x−1.8x−0.7x
PEG Ratio
1.01−0.180.00
Price/Book
5.7x1.4x2.6x
Price / LTM Sales
2.6x3.3x3.2x
Upside (Analyst Target)
18.6%22.8%43.9%
Fair Value Upside
Unlock10.8%6.5%Unlock

People Also Watch

248.41
COR
+0.26%
261.52
PGR
+2.45%
60.15
CNC
-3.79%
113.65
HWM
+2.18%

FAQ

What Is the IQVIA Holdings (IQV) Stock Price Today?

The IQVIA Holdings stock price today is 219.23

What Stock Exchange Does IQVIA Holdings Trade On?

IQVIA Holdings is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for IQVIA Holdings?

The stock symbol for IQVIA Holdings is "IQV."

What Is the IQVIA Holdings Market Cap?

As of today, IQVIA Holdings market cap is 39.79B.

What is IQVIA Holdings Earnings Per Share?

The IQVIA Holdings EPS is 7.72.

What Is the Next IQVIA Holdings Earnings Date?

IQVIA Holdings will release its next earnings report on 11 Feb 2025.

From a Technical Analysis Perspective, Is IQV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.